Related Experiment Video
Updated: Dec 9, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Extended multi-item gamma Poisson shrinker methods based on the zero-inflated Poisson model for postmarket drug
1Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.
Abstract:
Bayesian signal detection methods, including the multiitem gamma Poisson shrinker (MGPS), assume a Poisson distribution for the number of reports. However, the database of the adverse event reporting system often has a large number of zero-count cells. A zero-inflated Poisson (ZIP) distribution can be more appropriate in this situation than a Poisson distribution. Few studies have considered ZIP-based models for Bayesian signal detection. In addition, most studies on Bayesian signal detection methods include simulation studies conducted assuming a gamma distribution for the prior. Herein, we extend the MGPS method using the ZIP model and apply various prior distributions. We evaluated the extended methods through an extensive simulation using more varied settings for the model and prior than existing methods. We varied the total number of reports, the number of true signals, the relative reporting rate, and the probability of observing a true zero. The results show that as the probability of observing a zero count increased, methods based on the ZIP model outperformed the Poisson model in most cases. We also found that using the mixture log-normal prior resulted in more conservative detection than other priors when the relative reporting rate is high. Conversely, more signals were found when using the mixture truncated normal distributions. We applied the Bayesian signal detection methods to data from the Korea Adverse Event Reporting System from 2012 to 2016.
More Related Videos
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

